pyrimidin-2-one beta-ribofuranoside and Osteosarcoma
pyrimidin-2-one beta-ribofuranoside has been researched along with Osteosarcoma in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Han, H; Ma, B; Wang, J; Wang, S; Yang, Y; Ye, K | 1 |
| Graef, AJ; Kartha, RV; Korpela, DM; Modiano, JF; Park, C; Sarver, AL; Steer, CJ; Subramanian, S; Thayanithy, V | 1 |
Other Studies
2 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Osteosarcoma
| Article | Year |
|---|---|
Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; CpG Islands; Cytidine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Osteosarcoma; Protein Binding; rho GTP-Binding Proteins | 2016 |
Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chromatin; Cytidine; DNA; DNA Methylation; Dogs; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Osteosarcoma; Vorinostat | 2012 |